Yorktown Management & Research Company’s GSK GSK Stock Holding History

Yorktown Management & Research Company’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-4,000	Closed	-$217K	–	304
2016 Q2	$217K	Hold	4,000	–	–	0.05%	260
2016 Q1	$203K	Sell	4,000 -36,000	-90%	-$1.79M	0.04%	329
2015 Q4	$2.02M	Sell	40,000 -36,000	-47%	-$1.83M	0.36%	94
2015 Q3	$3.65M	Hold	76,000	–	–	0.6%	44
2015 Q2	$3.96M	Buy	76,000 +54,400	+252%	+$3.06M	0.69%	40
2015 Q1	$1.25M	Buy	+21,600	New	+$1.24M	0.23%	96
2014 Q3	–	Sell	-3,760	Closed	-$251K	–	476
2014 Q2	$251K	Hold	3,760	–	–	0.05%	317
2014 Q1	$251K	Hold	3,760	–	–	0.05%	310
2013 Q4	$251K	Hold	3,760	–	–	0.05%	297
2013 Q3	$236K	Hold	3,760	–	–	0.05%	266
2013 Q2	$235K	Buy	+3,760	New	+$239K	0.05%	227

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Yorktown Management & Research Company's GSK Position: Q3 2016 in Review

Yorktown Management & Research Company sold out of GSK (GSK) in Q3 2016, closing a stake of 4,000 shares — an estimated $217K sold.

Yorktown Management & Research Company first reported a position in GSK in Q2 2013 and held it in 11 quarters. The position peaked at $3.96M in Q2 2015. 741 funds tracked by Wall St. Rank hold GSK as of Q3 2016.

Yorktown Management & Research Company reported no remaining GSK position as of Q3 2016 after selling out during the quarter.
Yorktown Management & Research Company sold 4,000 GSK shares in Q3 2016, an estimated $217K.
Yorktown Management & Research Company first reported a position in GSK in Q2 2013 and held it in 11 quarters.
Yorktown Management & Research Company's GSK position peaked at $3.96M in Q2 2015.
741 funds tracked by Wall St. Rank held GSK as of Q3 2016.

Based on Yorktown Management & Research Company's 13F filing for Q3 2016, filed 31 Oct 2016.